Vaccine candidates protect primates against Zika virus
A month after announcing that two promising vaccine candidates provided mice with complete protection against the Zika virus, a research team at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Walter Reed Army Institute of Research (WRAIR) and the University of São Paulo, now reports achieving complete protection against Zika virus in rhesus monkeys. The research team's findings were published online today in the journal Science. This week Florida officials confirmed that fourteen people have contracted the Zika virus in Miami-Dade and Broward Counties, the first-known mosquito-borne transmission in the continental United States. The Centers for Disease Control and Prevention (CDC) recommended that pregnant women avoid these areas, which is the first time in history that is has recommended avoiding travel to regions within the continental United States. Because Zika infection in pregnant women has been shown to lead to fetal microcephaly and other major birth defects, developing a safe vaccine is an urgent global health priority.
"Three vaccines provided complete protection against Zika virus in nonhuman primates, which is the best animal model prior to starting clinical trials," said senior author Dan H. Barouch, MD, PhD, Director of the Center for Virology and Vaccine Research at BIDMC, Professor of Medicine at Harvard Medical School, and Steering Committee Member at the Ragon Institute of MGH, MIT and Harvard. "The consistent and robust protection against Zika virus in both rodents and primates fuels our optimism about the development of a safe and effective Zika vaccine for humans."
Vaccines work by stimulating the immune system to develop defenses against the virus. The researchers tested three means of producing Zika immunity in rhesus monkeys: a purified inactivated virus (PIV) vaccine developed by Army researchers at WRAIR and a plasmid DNA vaccine and an adenovirus vector-based vaccine produced at BIDMC. All three platforms proved strikingly effective, and no adverse effects were observed.
To test the PIV vaccine, scientists immunized eight rhesus monkeys with inactivated Zika virus and eight monkeys with a sham vaccine. Within two weeks, the animals' immune systems produced antibodies against the virus. After a booster shot at four weeks, the antibody levels increased substantially. When these animals were exposed to two strains of infectious Zika virus from Brazil and Puerto Rico, they showed complete protection against the virus, with no detectable Zika virus in the blood or other bodily secretions.
In a second experiment, 12 rhesus monkeys were immunized with either a DNA vaccine or an adenovirus vector-based vaccine. These types of vaccines introduce only a fragment of Zika virus DNA coding for the Zika virus' outer coat into the body. These vaccines led the immune system to develop antibodies. In this study, both vaccines produced Zika-specific antibodies in all primates tested, with the adenovirus vector-based vaccine provoking a broader and a more potent antibody response. When the primates were exposed to the Brazilian strain of Zika virus, both vaccines provided complete protection. These data suggest that clinical trials for these Zika virus vaccine candidates should proceed as quickly as possible.
Source: Beth Israel Deaconess Medical Center
Articles on the same topic
- Vaccine candidates protect against Zika virus in rhesus monkeysThu, 4 Aug 2016, 18:27:27 UTC
- Three vaccine approaches protect monkeys against Zika infectionThu, 4 Aug 2016, 18:27:04 UTC
- Zika infection is caused by one virus serotype, NIH study findsFri, 29 Jul 2016, 17:07:30 UTC
- Conception timed with periods of low mosquito activity could reduce Zika virus infectionThu, 28 Jul 2016, 18:41:41 UTC
- Mouse antibodies pinpoint Zika's weak spotsWed, 27 Jul 2016, 16:35:43 UTC
- Antibodies identified that thwart Zika virus infectionWed, 27 Jul 2016, 16:35:33 UTC
- Studies in mice provide insights into antibody-Zika virus interactionsWed, 27 Jul 2016, 16:35:22 UTC
- Could the deadly mosquito-borne yellow fever virus cause a Zika-like epidemic in the Americas?Tue, 26 Jul 2016, 19:36:29 UTC
- Cracking the mystery of Zika virus replicationTue, 26 Jul 2016, 15:08:04 UTC
- Researchers 'solve' key Zika virus protein structureMon, 25 Jul 2016, 18:05:17 UTC
- Study suggests 1.6 million childbearing women could be at risk of Zika virus infectionMon, 25 Jul 2016, 18:05:07 UTC
- Researchers make new projections for spread of the Zika virusMon, 25 Jul 2016, 18:04:57 UTC
Other sources
- Vaccine candidates protect primates against Zika virusfrom Biology News NetThu, 4 Aug 2016, 22:31:15 UTC
- Vaccine candidates protect against Zika virus in rhesus monkeysfrom Science DailyThu, 4 Aug 2016, 20:11:10 UTC
- Three vaccines prevent Zika infection in monkeys; vaccine trial in humans gets underwayfrom LA Times - ScienceThu, 4 Aug 2016, 19:51:15 UTC
- 3 Zika vaccines effective in monkeysfrom UPIThu, 4 Aug 2016, 18:31:51 UTC
- Zika vaccines work in monkeys, boosting hopes for peoplefrom AP HealthThu, 4 Aug 2016, 18:31:37 UTC
- Three Zika Vaccines Show Success In Animal Modelsfrom PopSciThu, 4 Aug 2016, 18:21:32 UTC
- Florida’s $82 Billion Tourism Industry Braces for Zikafrom NY Times HealthThu, 4 Aug 2016, 17:11:18 UTC
- NIH begins testing investigational Zika vaccine in humansfrom Science BlogWed, 3 Aug 2016, 22:31:22 UTC
- New Zika Vaccine: Testing in People Underway in USfrom Live ScienceWed, 3 Aug 2016, 21:31:10 UTC
- U.S. launches early trial of Zika vaccinefrom UPIWed, 3 Aug 2016, 18:31:16 UTC
- NIH Is Testing A Potential Zika Vaccine In Peoplefrom PopSciWed, 3 Aug 2016, 17:31:45 UTC
- Poll: 77 percent of Americans not seriously worried about Zika virusfrom UPIWed, 3 Aug 2016, 12:01:09 UTC
- Antibodies identified that thwart Zika virus infectionfrom Science BlogMon, 1 Aug 2016, 18:41:15 UTC
- Zika Cases in Puerto Rico Are Skyrocketingfrom NY Times ScienceSun, 31 Jul 2016, 6:01:24 UTC
- Vaccination: Zika infection is caused by one virus serotypefrom Science DailyFri, 29 Jul 2016, 18:01:30 UTC
- Conception timed with periods of low mosquito activity could reduce Zika virus infectionfrom Science DailyThu, 28 Jul 2016, 19:31:18 UTC
- Zika, other mosquito-borne illnesses pose threat to travelersfrom Science DailyThu, 28 Jul 2016, 19:01:16 UTC
- Mouse antibodies pinpoint Zika's weak spotsfrom Biology News NetWed, 27 Jul 2016, 22:11:14 UTC
- Studies in mice provide insights into antibody-Zika virus interactionsfrom Science DailyWed, 27 Jul 2016, 19:01:17 UTC
- Cracking the mystery of Zika virus replicationfrom Biology News NetTue, 26 Jul 2016, 19:51:07 UTC
- Cracking the mystery of Zika virus replicationfrom Science DailyTue, 26 Jul 2016, 17:31:28 UTC
- Researchers make new projections for spread of the Zika virusfrom Science BlogMon, 25 Jul 2016, 21:01:36 UTC
- Researchers 'solve' key Zika virus protein structurefrom Science DailyMon, 25 Jul 2016, 18:01:29 UTC
- Colombia declares end to Zika epidemic inside countryfrom CBC: HealthMon, 25 Jul 2016, 18:01:04 UTC
- 1.6 million childbearing women could be at risk of Zika virus infection, study suggestsfrom Science DailyMon, 25 Jul 2016, 17:31:25 UTC
- Researchers 'solve' key Zika virus protein structurefrom PhysorgMon, 25 Jul 2016, 16:01:18 UTC